NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market on Thursday that its fourth-quarter revenues decreased 2.6 percent — but increased 3 percent on a currency-neutral basis — as sales for its life science business segment slumped nearly 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.